Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT

  1. Battipaglia, G.
  2. Mauff, K.
  3. Wendel, L.
  4. Angelucci, E.
  5. Mohty, M.
  6. Arcese, W.
  7. Santarone, S.
  8. Rubio, M.T.
  9. Kroger, N.
  10. Fox, M.L.
  11. Blaise, D.
  12. Iori, A.P.
  13. Fanin, R.
  14. Chalandon, Y.
  15. Pioltelli, P.
  16. Marotta, G.
  17. Chiusolo, P.
  18. Sever, M.
  19. Solano, C.
  20. Contentin, N.
  21. de Wreede, L.C.
  22. Czerw, T.
  23. Hernandez-Boluda, J.C.
  24. Hayden, P.
  25. McLornan, D.
  26. Yakoub-Agha, I.
  27. Erakutsi egile guztiak +
Aldizkaria:
Bone Marrow Transplantation

ISSN: 1476-5365 0268-3369

Argitalpen urtea: 2021

Alea: 56

Zenbakia: 7

Orrialdeak: 1593-1602

Mota: Artikulua

DOI: 10.1038/S41409-021-01222-Z GOOGLE SCHOLAR